Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.2055 SEK | -5.08% | -4.64% | -97.94% |
May. 02 | Xbrane Biopharma AB Appoints Kristoffer Bissessar Was Elected as New Director | CI |
Apr. 22 | Transcript : Xbrane Biopharma AB - Special Call |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-97.94% | 30.18M | |
+26.28% | 42.68B | |
-3.99% | 42.4B | |
+45.32% | 40.04B | |
-6.20% | 28.31B | |
+6.36% | 24.94B | |
-21.47% | 18.96B | |
+27.58% | 12.3B | |
-2.75% | 11.95B | |
-2.02% | 11.55B |
- Stock Market
- Equities
- XBRANE Stock
- News Xbrane Biopharma AB
- Xbrane Biopharma, Stada Jointly Launch Lucentis Biosimilar in Germany